Extending Drug Monopolies by Patenting Safe Drug Use
JAMA Intern Med
.
2022 Mar 1;182(3):245-246.
doi: 10.1001/jamainternmed.2021.7954.
Authors
Doni Bloomfield
1
,
Bryan S Walsh
1
,
Aaron S Kesselheim
1
Affiliation
1
Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
PMID:
35099499
DOI:
10.1001/jamainternmed.2021.7954
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Commerce*
Humans
Substance-Related Disorders*